Untitled

I N D U S T RY N E W S A N D I N N O VAT I O N S
JDRF Names Islet Cell Transplant Center
The Juvenile Diabetes Research Foundation (JDRF) has Islet Transplant Fellowship program for training endocri- named The City of Hope National Medical Center in Los Angeles as a JDRF Islet Cell Transplant Center. “As a JDRF center, we are confident that the City of The islet transplantation program at The City of Hope Hope can continue its rapid development of research has performed the second most islet transplants in and treatment programs in islet cell supply and trans- North America during 2004 and 2005. The University of plantation, which will certainly be a significant addition Edmonton, which developed the protocol for human to our efforts to accelerate the pace of research leading islet cell transplantation in 2000, has performed the to the development of cures and treatments for type 1 most. The institution has been designated as one of only diabetes and its complications,” said Richard A. Insel, MD, a handful of Islet Cell Resource Centers by the National executive vice president of research in a news release. For Institutes of Health/JDRF. It developed the first Clinical more information, please visit www.jdrf.org.
Avocado Oil Marketed
Insulet, Aetna
For Healthy Eating
Announce Agreement
Olivado Gourmet Foods (Kerikeri, New Zealand) has Insulet (Bedford, Mass), developer and manufacturer created an avocado-based cooking oil. Made from avoca- of OmniPod Insulin Management System, has signed an agreement with Aetna US Healthcare (Hartford, Conn) adding the OmniPod System to Aetna’s network of cov- “This agreement with Aetna is a major milestone in Insulet’s ongoing mission to improve the lives of people with diabetes,” said Duane DeSisto, president and CEO of Insulet, in a news release. “It makes the OmniPod System — and continuous subcutaneous insulin infusion thera- py, considered one of the best therapies for insulin- dependent diabetes — more accessible to Aetna mem- bers living with diabetes in the United States.” intake of antioxidants and other beneficial nutrients.
For more information, please visit www.myomnipod.
Avocados also contain high amounts of lutein alpha and beta-carotene. For more informaton, please visit www.oli-vado.com.
Generex Launches
FDA Approves Duetact
New Form of Glucose
Generex Biotechnology (Toronto), an innovator of approved Duetact (Takeda Pharmaceuticals, drug delivery systems, launched a new over-the-counter Lincolnshire, Ill), a combination therapy for the treat- Glucose Rapid Spray product at the American Associ- ation of Diabetes Educators 33rd Annual Meeting & Duetact combines pioglitazone and glimepiride, in a single tablet. Combining these medications may provide Glucose Rapid Spray is an alternative for people who patients with an easier way to take the two drugs.
require or want additional glucose in their diet; the prod- Duetact will be available in two commonly used uct delivers fat-free low-calorie glucose formulation dosages taken once daily and is expected to be available directly into the mouth where it is rapidly absorbed. For to patients later this year. For more information, please more information, please visit www.generex.com/prod- visit www.tpna.com/prdetail.asp?articleid=125.
SEPTEMBER/OCTOBER 2006 I DIABETIC MICROVASCULAR COMPLICATIONS TODAY I 49

Source: http://www.diabeticmctoday.com/HtmlPages/DMC0906/DMC0906_Inno.pdf